Rani Therapeutics Holdings Inc (RANI)

Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	4.47% 14.03	13.43	17.86	18.29	16.52
Interest Income/Expense	0.15% 1.294	1.296	1.316	1.266	1.207
Depreciation and Amortization	9.25% 0.248	0.227	0.218	0.189	0.188
Operating Income/Loss	4.47% -14.03	-13.43	-17.86	-18.29	-16.52
Income/Loss From Continuing Operations Before Tax	5.15% -14.78	-14.05	-18.33	-18.66	-16.83
Income/Loss From Continuing Operations After Tax	5.15% -14.78	-14.05	-18.33	-18.66	-16.83
Net Income/Loss	5.15% -14.78	-14.05	-18.33	-18.66	-16.83
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	4.87% -7.296	-6.957	-9.135	-9.361	-8.46
Basic Average Shares	202.68% 26.03	-25.35	25.55	25.34	25.24
Diluted Average Shares	202.68% 26.03	-25.35	25.55	25.34	25.24
Basic Earnings Per Share	87.87% -0.29	-2.39	0.36	0.37	0.33
Diluted Earnings Per Share	87.87% -0.29	-2.39	0.36	0.37	0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-